Quest Diagnostics Incorporated Q3 2026 Earnings Recap

Quest reported 10% revenue growth and raised its full-year revenue and EPS guidance; with the stock up 1.8%, the reaction was modest rather than a clear endorsement. The transcript cites broad channel growth and productivity gains, though the excerpt does not provide the revised guidance figures.

Key Takeaways

• Revenue grew 10% and adjusted EPS increased more than 15% in the quarter.
• Physician-channel revenue grew at a high-single-digit rate; hospital revenue grew by double digits, while reference testing revenue was up mid-single digits.
• Quest expects consumer-health growth to exceed 30% for the full year and plans to launch Apple Health app lab ordering later this year.
• Key advanced diagnostic tests, including in cardiometabolic, hormone, and Alzheimer’s disease areas, grew by double digits.
• The company said it remains on track to deliver 3% in annual cost savings and productivity improvements through Invigora.